혈류 전환 동맥류 치료 시장 - 세계 산업 규모, 점유율, 동향, 기회, 예측 : 제품별(FDS, 낭내 혈류 전환 기기), 최종사용자별(병원, 전문 클리닉), 지역별, 경쟁별(2020-2030년)

Flow Diversion Aneurysm Treatment Market- Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Product (FDS, Intrasaccular flow disruption devices), By End User (Hospitals, Specialty clinics), By Region & Competition, 2020-2030F

US $ 4,500 ￦ 6,233,000

Unprintable PDF (Single User License)

PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 불가능하며, 텍스트의 Copy&Paste도 불가능합니다.

US $ 5,500 ￦ 7,619,000

PDF and Excel (Multi-User License)

PDF 및 Excel 보고서를 기업의 팀이나 기관에서 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 및 Excel 이용 범위와 동일합니다.

US $ 8,000 ￦ 11,082,000

PDF and Excel (Custom Research License)

PDF 및 Excel 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 및 Excel 이용 범위와 동일합니다. 80시간의 애널리스트 타임이 포함되어 있고 Copy & Paste 가능한 PPT 버전도 제공됩니다. 짧은 Bespoke 리서치 프로젝트 수행에 맞는 라이선스입니다.

한글목차

혈류 전환 동맥류 치료 세계 시장 규모는 2024년 19억 8,000만 달러로 2030년까지 연평균 성장률(CAGR) 7.72%로 예측 기간 동안 큰 성장을 보일 것으로 예상됩니다.

이 시장은 생명을 위협할 수 있는 뇌동맥류에 대한 긴급한 대처가 필요함에 따라 신경중재술 분야에서 빠르게 발전하고 있습니다. 이 시장의 특징은 동맥류에서 혈류를 우회시켜 막힘을 돕고 파열의 위험을 줄이기 위해 고안된 최소침습적 치료인 우회장치의 사용입니다. 혈류 전환 기술과 신경 영상 기술의 끊임없는 발전은 치료 옵션을 넓히고 환자 결과를 개선하고 있습니다. 뇌동맥류 발생률의 증가는 종종 노화 및 기타 위험 요인과 관련이 있어 효과적인 치료 솔루션에 대한 수요를 더욱 증가시키고 있습니다. 기존의 수술적 접근 방식에 비해 유체전환술은 덜 침습적이어서 회복 시간이 짧고 입원 기간이 짧아집니다.

시장 개요
예측 기간	2026-2030년
시장 규모 : 2024년	19억 8,000만 달러
시장 규모 : 2030년	30억 7,000만 달러
CAGR : 2025-2030년	7.72%
급성장 부문	FDS
최대 시장	북미

시장 촉진요인

시장의 과제

혈류 전환 기기는 매우 효과적이지만 고가이며, 이러한 특수 기기의 비용은 전체 치료 비용의 상당 부분을 차지합니다.

혈류 전환술을 시행하기 위해서는 전문적인 교육이 필요하며, 이를 위한 교육 및 자격증 취득을 위한 추가 비용이 발생합니다.

또한, 수술 전 평가, 장기 입원, 후속 치료의 복잡성도 전체 의료 비용을 증가시킵니다.

기기와 의료 도구의 기술적 발전은 더 나은 치료 결과를 가져올 수 있는 반면, 초기 비용이 높아질 가능성도 있습니다.

주요 시장 동향

디자인, 재료, 전달 시스템 개선 등 유체 우회장치의 지속적인 기술 혁신으로 안전성과 유효성이 향상되어 도입이 더욱 촉진되고 있습니다.

목차

제1장 개요

제2장 조사 방법

제3장 주요 요약

제4장 고객의 소리

제5장 세계의 혈류 전환 동맥류 치료 시장 전망

• 시장 규모 및 예측
  • 금액별
• 시장 점유율과 예측
  • 제품별(FDS, 낭내 혈류 차단 기기)
  • 최종사용자별(병원, 전문 클리닉)
  • 지역별
  • 기업별(2024)
• 시장 맵

제6장 북미의 혈류 전환 동맥류 치료 시장 전망

• 시장 규모 및 예측
• 시장 점유율과 예측
• 북미 : 국가별 분석
  • 미국
  • 캐나다
  • 멕시코

제7장 유럽의 혈류 전환 동맥류 치료 시장 전망

• 시장 규모 및 예측
• 시장 점유율과 예측
• 유럽 : 국가별 분석
  • 독일
  • 영국
  • 이탈리아
  • 프랑스
  • 스페인

제8장 아시아태평양의 혈류 전환 동맥류 치료 시장 전망

• 시장 규모 및 예측
• 시장 점유율과 예측
• 아시아태평양 : 국가별 분석
  • 중국
  • 인도
  • 일본
  • 한국
  • 호주

제9장 남미의 혈류 전환 동맥류 치료 시장 전망

• 시장 규모 및 예측
• 시장 점유율과 예측
• 남미 : 국가별 분석
  • 브라질
  • 아르헨티나
  • 콜롬비아

제10장 중동 및 아프리카의 혈류 전환 동맥류 치료 시장 전망

• 시장 규모 및 예측
• 시장 점유율과 예측
• 중동 및 아프리카 : 국가별 분석
  • 남아프리카공화국
  • 사우디아라비아
  • 아랍에미리트

제11장 시장 역학

• 성장 촉진요인
• 과제

제12장 시장 동향과 발전

• 최근 동향
• 제품 출시
• 인수합병

제13장 세계의 혈류 전환 동맥류 치료 시장 : SWOT 분석

제14장 경쟁 구도

• Acandis GmbH
• BALT Group
• Cardinal Health Inc
• Endologix LLC
• Evasc Medical Systems Corp
• Imperative Care Inc
• InspireMD Inc
• Johnson and Johnson
• Lepu Medical Technology Beijing Co. Ltd
• Medtronic Plc

제15장 전략적 제안

제16장 조사 회사 소개 및 면책사항

ksm

영문 목차

영문목차

The global Flow Diversion Aneurysm Treatment Market was valued at USD 1.98 billion in 2024 and is projected to experience significant growth during the forecast period, with a compound annual growth rate (CAGR) of 7.72% through 2030. This market is evolving rapidly within the neurointerventional sector, driven by the urgent need to address cerebral aneurysms, a potentially life-threatening condition. The market is characterized by the use of flow diversion devices, a minimally invasive treatment designed to reroute blood flow away from aneurysms, aiding in their occlusion and reducing the risk of rupture. Continuous advancements in flow diversion technologies and neuroimaging techniques are broadening treatment options and enhancing patient outcomes. The rising incidence of cerebral aneurysms, often linked to aging and other risk factors, is further propelling demand for effective treatment solutions. Compared to traditional surgical approaches, flow diversion procedures are less invasive, leading to shorter recovery times and reduced hospital stays.

Market Overview
Forecast Period	2026-2030
Market Size 2024	USD 1.98 Billion
Market Size 2030	USD 3.07 Billion
CAGR 2025-2030	7.72%
Fastest Growing Segment	FDS
Largest Market	North America

Key Market Drivers

The Flow Diversion Aneurysm Treatment Market is experiencing notable growth, primarily driven by the increasing adoption of minimally invasive treatment options. This trend reflects a shift in the management of cerebral aneurysms, prioritizing less invasive procedures over traditional open surgeries. Several factors contributing to this shift include:

Minimally invasive procedures typically require smaller incisions or access points, resulting in reduced tissue damage, less pain, and faster recovery times compared to open surgery. This approach is highly appealing to both patients and healthcare providers.

Flow diversion treatments yield excellent patient outcomes, with lower complication rates and reduced risks of infection or bleeding, which boosts patient satisfaction and enhances the reputation of these procedures.

Advances in medical devices and imaging technologies have made minimally invasive treatments more precise and effective. Real-time imaging guidance plays a critical role in increasing the accuracy of flow diversion procedures.

Key Market Challenges

Despite the promising growth of the market, high procedural costs remain a significant challenge. These costs encompass various aspects of treatment, including the price of flow diversion devices, hospital fees, physician charges, and post-procedure care. Contributing factors to the elevated costs include:

Flow diversion devices, while highly effective, can be expensive, and the cost of these specialized devices forms a substantial part of the overall treatment expenses.

Performing flow diversion procedures requires specialized training, which incurs additional costs for education and certification.

The complexity of pre-operative assessments, extended hospital stays, and follow-up care also increases overall healthcare costs.

While technological advancements in devices and medical tools may lead to better outcomes, they can also result in higher upfront costs.

Reimbursement rates for flow diversion procedures in some healthcare systems may not fully cover the costs, creating financial constraints for hospitals and healthcare providers. High procedural costs can also limit patient access to these advanced treatments.

Addressing these challenges requires a multi-pronged approach, including optimizing the cost-effectiveness of flow diversion devices, improving reimbursement strategies, and expanding access to specialized care. Overcoming these barriers is essential to ensuring equitable patient access to life-saving treatments and ensuring the sustainability of healthcare systems.

Key Market Trends

A growing adoption of flow diversion techniques is a prominent trend in the market, with an increasing preference for flow diversion procedures as the primary method for managing cerebral aneurysms. Key factors contributing to this trend include:

Flow diversion procedures are less invasive compared to traditional open surgeries, attracting patients seeking treatments that offer quicker recovery times, reduced pain, and smaller incisions.

Flow diversion techniques have proven to be highly effective in treating complex aneurysms, such as wide-necked and fusiform aneurysms, that were previously difficult to manage. This effectiveness has led to greater trust and acceptance among both physicians and patients.

Ongoing innovations in flow diversion devices, including improvements in design, materials, and delivery systems, have enhanced their safety and efficacy, further promoting adoption.

Patients undergoing flow diversion procedures often experience positive outcomes, including lower rates of aneurysm recurrence and fewer complications, contributing to higher patient satisfaction and confidence in the treatment.

An increasing number of neurointerventionalists are being trained in flow diversion techniques, expanding the availability of these procedures in medical centers globally. The growing body of clinical evidence supporting the effectiveness of flow diversion in preventing aneurysm rupture is further driving its adoption.

Key Market Players

• Acandis GmbH
• BALT Group
• Cardinal Health Inc
• Endologix LLC
• Evasc Medical Systems Corp
• Imperative Care Inc
• InspireMD Inc
• Johnson & Johnson
• Lepu Medical Technology Beijing Co. Ltd
• Medtronic Plc

Market Segmentation

This report segments the global Flow Diversion Aneurysm Treatment Market into the following categories:

By Product:

• Flow Diverter Stents (FDS)
• Intrasaccular Flow Disruption Devices

By End User:

• Hospitals
• Specialty Clinics

By Region:

• North America (United States, Canada, Mexico)
• Europe (France, United Kingdom, Italy, Germany, Spain)
• Asia-Pacific (China, India, Japan, Australia, South Korea)
• South America (Brazil, Argentina, Colombia)
• Middle East & Africa (South Africa, Saudi Arabia, UAE)

Competitive Landscape

The report provides a detailed analysis of the major players in the Flow Diversion Aneurysm Treatment Market, including their strategies, market share, and key business developments.

Available Customizations

TechSci Research offers customizations for this global Flow Diversion Aneurysm Treatment Market report according to specific company needs. Customization options include:

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Flow Diversion Aneurysm Treatment Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Product (FDS, Intrasaccular flow disruption devices)
  • 5.2.2. By End User (Hospitals, Specialty clinics)
  • 5.2.3. By Region
  • 5.2.4. By Company (2024)
• 5.3. Market Map

6. North America Flow Diversion Aneurysm Treatment Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Product
  • 6.2.2. By End User
  • 6.2.3. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Flow Diversion Aneurysm Treatment Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Product
      • 6.3.1.2.2. By End user
  • 6.3.2. Canada Flow Diversion Aneurysm Treatment Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Product
      • 6.3.2.2.2. By End user
  • 6.3.3. Mexico Flow Diversion Aneurysm Treatment Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Product
      • 6.3.3.2.2. By End user

7. Europe Flow Diversion Aneurysm Treatment Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Product
  • 7.2.2. By End User
  • 7.2.3. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. Germany Flow Diversion Aneurysm Treatment Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Product
      • 7.3.1.2.2. By End user
  • 7.3.2. United Kingdom Flow Diversion Aneurysm Treatment Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Product
      • 7.3.2.2.2. By End user
  • 7.3.3. Italy Flow Diversion Aneurysm Treatment Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecasty
      • 7.3.3.2.1. By Product
      • 7.3.3.2.2. By End user
  • 7.3.4. France Flow Diversion Aneurysm Treatment Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Product
      • 7.3.4.2.2. By End user
  • 7.3.5. Spain Flow Diversion Aneurysm Treatment Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Product
      • 7.3.5.2.2. By End user

8. Asia-Pacific Flow Diversion Aneurysm Treatment Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Product
  • 8.2.2. By End User
  • 8.2.3. By Country
• 8.3. Asia-Pacific: Country Analysis
  • 8.3.1. China Flow Diversion Aneurysm Treatment Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Product
      • 8.3.1.2.2. By End user
  • 8.3.2. India Flow Diversion Aneurysm Treatment Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Product
      • 8.3.2.2.2. By End user
  • 8.3.3. Japan Flow Diversion Aneurysm Treatment Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Product
      • 8.3.3.2.2. By End user
  • 8.3.4. South Korea Flow Diversion Aneurysm Treatment Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Product
      • 8.3.4.2.2. By End user
  • 8.3.5. Australia Flow Diversion Aneurysm Treatment Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Product
      • 8.3.5.2.2. By End user

9. South America Flow Diversion Aneurysm Treatment Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Product
  • 9.2.2. By End User
  • 9.2.3. By Country
• 9.3. South America: Country Analysis
  • 9.3.1. Brazil Flow Diversion Aneurysm Treatment Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Product
      • 9.3.1.2.2. By End user
  • 9.3.2. Argentina Flow Diversion Aneurysm Treatment Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Product
      • 9.3.2.2.2. By End user
  • 9.3.3. Colombia Flow Diversion Aneurysm Treatment Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Product
      • 9.3.3.2.2. By End user

10. Middle East and Africa Flow Diversion Aneurysm Treatment Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Product
  • 10.2.2. By End User
  • 10.2.3. By Country
• 10.3. MEA: Country Analysis
  • 10.3.1. South Africa Flow Diversion Aneurysm Treatment Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Product
      • 10.3.1.2.2. By End user
  • 10.3.2. Saudi Arabia Flow Diversion Aneurysm Treatment Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Product
      • 10.3.2.2.2. By End user
  • 10.3.3. UAE Flow Diversion Aneurysm Treatment Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Product
      • 10.3.3.2.2. By End user

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Recent Developments
• 12.2. Product Launches
• 12.3. Mergers & Acquisition

13. Global Flow Diversion Aneurysm Treatment Market: SWOT Analysis

14. Competitive Landscape

• 14.1. Acandis GmbH
  • 14.1.1. Business Overview
  • 14.1.2. Treatment Offerings
  • 14.1.3. Recent Developments
  • 14.1.4. Key Personnel
  • 14.1.5. SWOT Analysis
• 14.2. BALT Group
• 14.3. Cardinal Health Inc
• 14.4. Endologix LLC
• 14.5. Evasc Medical Systems Corp
• 14.6. Imperative Care Inc
• 14.7. InspireMD Inc
• 14.8. Johnson and Johnson
• 14.9. Lepu Medical Technology Beijing Co. Ltd
• 14.10.Medtronic Plc

15. Strategic Recommendations

16. About Us & Disclaimer

관련자료